Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health ...

Cencora reported first-quarter fiscal 2025 ... International Healthcare Solutions This segment includes Alliance Healthcare, World Courier, Innomar and Profarma Specialty. Revenues amounted ...

Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution ...

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 8.3% over the past month. The stock hit a new 52-week high of $271.86 in the previous session.

Cencora COR has outperformed the market over the past 10 years by 7.55% on an annualized basis producing an average annual return of 18.31%. Currently, Cencora has a market capitalization of $52. ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Baird raised the firm’s price target on Cencora (COR) to $307 from $305 and keeps an Outperform rating on the shares. The firm noted it was another beat and raise quarter. Published first on ...